期刊文献+

类风湿关节炎治疗靶点及药物研究进展

下载PDF
导出
摘要 类风湿关节炎(RA)是一种病因不明的自身免疫性疾病。传统的治疗RA的药物有3类,即非甾体抗炎药(non—steroidalantiinflammatorydrug,NSAID)、甾体抗炎药和疾病调理性抗风湿药(disease—modifyingantirheumaticdrug,DMARD)。这些药物或有毒性,或容易失效,或二者兼而有之,并不是理想的治疗RA的药物。
出处 《中国药师》 CAS 2008年第8期908-910,共3页 China Pharmacist
基金 国家自然科学资金(30672655)
  • 相关文献

参考文献18

  • 1郭丽丽.T细胞在类风湿性关节炎中的作用[J].上海免疫学杂志,2002,22(3):213-214. 被引量:19
  • 2Isomaki P, Luukkainen R, Lassila O, et al. Svnovial fluid T cells from patients with rheumatoid arthritis ate refractory to the T helper type 2 diferentiation inducing efeets of interleukin-4 [ J ]. Immunology, 1999,96 : 358
  • 3Bradfield PF, Amft N,Vernon WE,et al. Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factorl (CXCL12) ,which supports distinct patterns and rates of CD4 and CD8 T cellmigration within synovial tissue [ J ]. Arthritis Rheum, 2003,48 ( 9 ) : 2472 -2482
  • 4Kremer JM,Dougados M,Emery P,et al. Treatment of rheumatoid arthritis with the selective costimuiation moculator abatacept:twelve-month results of a phase iib, double-blind, randomized, placebo-contrelled trial [ J ]. Arthritis Rheum, 2005,52(8) :2263- 2271
  • 5田新平,唐福林,张奉春.T细胞受体疫苗与类风湿关节炎[J].中华风湿病学杂志,2003,7(12):758-761. 被引量:6
  • 6李元,张治平,吴倩,刘伯英,郭连宏,张洋,吴剑波.白细胞介素1受体新型拮抗剂研究[J].医学研究通讯,2002,31(2):6-9. 被引量:2
  • 7Garfield BE,Krahl T,Appel S,et al. Regulation of p38 MAP kinase in CD4( + ) lymphocytes by infliximab therapy in patients with rheumatoid arthritis [ J ]. Clin Immunol, 2005,116 ( 2 ) : 101 - 107
  • 8Maino VC, Piker LJ. identification of functional subsets by flowcytome-try:intracellular detection of cytokine expression [ J ]. Cytometry, 1998,34:207
  • 9王豫萍,肖林生,周艳,费樱,李君萍.类风湿性关节炎与转化生长因子β1基因多态性[J].中国公共卫生,2007,23(11):1405-1406. 被引量:4
  • 10张卫东.以B细胞为靶标的类风湿性关节炎的治疗[J].国外医学(药学分册),2006,33(6):448-451. 被引量:1

二级参考文献63

  • 1王玉玺,李汉保.雷公藤制剂的研究进展[J].中草药,1997,28(1):52-55. 被引量:13
  • 2温加登.西氏内科学[M].北京:世界图书出版社,1995.892.
  • 3[1]Cornelia M,Weyand CM,Schmidt D,et al.T-cell responses in rheumatoid arthritis: systemic abnormalities-local disease [J].Curr Opin Rheumatol,1999,11: 210
  • 4[2]Park W,Weyand CM,Schmidt D,et al.Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+ CD28'T cell[J].Eur J Immunol,1997,27:1082
  • 5[3]Isomaki P,Luukkainen R,Lassila O,et al.Synovial fluid T cells from patients with rheumatoid arthritis are refractory to the T helper type 2 differentiation-inducing effects of interleukin-4 [J ].Immunology,1999,96:358
  • 6[4]Franz JK,Kolb SA,Hummel KM,et al.Interleukin-16,produced by synovial fibroblasts,mediates chemoattraction for CD4 + T lymphoeytes in rheumatoid arthritis[J].Eur J Immunol,1998,28:2661
  • 7[5]Oppenheimer-Marks N,Brezinschek RI,Mohamadzadeh M,et al.Interleukin 15 is produecd by endothelial cells and increases the transendothelial migration of T cells in vitro and in the SCID mousehuman rheumatoid arthritis model in vivo[J].J Clin Invest,1998,101:1261
  • 8[6]Suzuki N,Nakajime A,Yoshino S,et al.Selective accumulation of CCR5 T lymphocytes into inflammed joints of rheumatoid arthritis[J].Int Immunol,1999,11:553
  • 9[7]Qin S,Rottman JB,Myers P,et al.The chemokine receptors CXCR3 and CXCR5 mark subsets of T cells associated with certain inflammatory reactions[J].J Clin Invest,1998,101:746
  • 10[8]Salmon M,Scheel-Toellner D,Huissoon AP,et al.Inhibition of T cell apoptosis in the rheumatoid synovium[J].J Clin Invest,1997,99:439

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部